Sequential transcatheter aortic valve implantation due to valve dislodgement: a Portico valve implanted over a CoreValve bioprosthesis

TY - JOUR

T1 - Sequential transcatheter aortic valve implantation due to valve dislodgement

T2 - a Portico valve implanted over a CoreValve bioprosthesis

AU - Campante Teles, Rui

AU - Costa, Cátia

AU - Almeida, Manuel

AU - Brito, João

AU - Sondergaard, Lars

AU - Neves, José P

AU - Abecasis, João

AU - M Gabriel, Henrique

N1 - Copyright © 2017 Sociedade Portuguesa de Cardiologia. Publicado por Elsevier España, S.L.U. All rights reserved.

PY - 2017/3/1

Y1 - 2017/3/1

N2 - Transcatheter aortic valve implantation (TAVI) has become an important treatment in high surgical risk patients with severe aortic stenosis (AS), whose complications need to be managed promptly. The authors report the case of an 86-year-old woman presenting with severe symptomatic AS, rejected for surgery due to advanced age and comorbidities. The patient underwent a first TAVI, with implantation of a Medtronic CoreValve®, which became dislodged and migrated to the ascending aorta. Due to the previous balloon valvuloplasty, the patient's AS became moderate, and her symptoms improved. After several months, she required another intervention, performed with a St. Jude Portico®repositionable self-expanding transcatheter aortic valve. There was a good clinical response that was maintained at one-year follow-up. The use of a self-expanding transcatheter bioprosthesis with repositioning features is a solution in cases of valve dislocation to avoid suboptimal positioning of a second implant, especially when the two valves have to be positioned overlapping or partially overlapping each other.

AB - Transcatheter aortic valve implantation (TAVI) has become an important treatment in high surgical risk patients with severe aortic stenosis (AS), whose complications need to be managed promptly. The authors report the case of an 86-year-old woman presenting with severe symptomatic AS, rejected for surgery due to advanced age and comorbidities. The patient underwent a first TAVI, with implantation of a Medtronic CoreValve®, which became dislodged and migrated to the ascending aorta. Due to the previous balloon valvuloplasty, the patient's AS became moderate, and her symptoms improved. After several months, she required another intervention, performed with a St. Jude Portico®repositionable self-expanding transcatheter aortic valve. There was a good clinical response that was maintained at one-year follow-up. The use of a self-expanding transcatheter bioprosthesis with repositioning features is a solution in cases of valve dislocation to avoid suboptimal positioning of a second implant, especially when the two valves have to be positioned overlapping or partially overlapping each other.

U2 - 10.1016/j.repc.2016.03.012

DO - 10.1016/j.repc.2016.03.012

M3 - Journal article

C2 - 28259370

SN - 0870-2551

VL - 36

SP - 215.e1-215.e4

JO - Revista Portuguesa de Cardiologia

JF - Revista Portuguesa de Cardiologia

IS - 3

ER -